Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma
Quach, Hang, Benson, Simon, Haysom, Helen, Wilkes, Anne‐Marie, Zacher, Nicole, Cole‐Sinclair, Merrole, Miles Prince, Henry, Mollee, Peter, Spencer, Andrew, Joy Ho, Phoebe, Harrison, Simon J., Lee, Cindy, Augustson, Bradley, Daly, James
Published in Internal medicine journal (01.02.2018)
Published in Internal medicine journal (01.02.2018)
Get full text
Journal Article
Quality of Life Related to Oral versus Subcutaneous Iron Chelation: A Time Trade-off Study
Osborne, Richard H., BSc, PhD, De Abreu Lourenço, Richard, BEc(Hons), MEc(Hons), Dalton, Andrew, BEc, MEc, Houltram, Jennifer, BSc(Hons), Dowton, David, BAppSc(Hons), Joshua, Douglas Edgar, BSc, MBBS, DPhil(Oxon), FRACP, FRCPA, Lindeman, Robert, MBBS, FRACP, FRCPA, PhD, Phoebe Joy, Ho, MBBS(Syd), DPhil(Oxon), FRACP, FRCPA
Published in Value in health (01.11.2007)
Published in Value in health (01.11.2007)
Get full text
Journal Article
Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox
Viprakasit, Vip, Ibrahim, Hishamshah, Ha, Shau-Yin, Ho, Phoebe Joy, Li, Chi-Kong, Chan, Lee-Lee, Chiu, Chang-Fang, Sutcharitchan, Pranee, Habr, Dany, Domokos, Gabor, Roubert, Bernard, Xue, Hong-Ling, Bowden, Donald K., Lin, Kai-Hsin
Published in International journal of hematology (01.03.2011)
Published in International journal of hematology (01.03.2011)
Get full text
Journal Article
Treg and Oligoclonal Expansion of Terminal Effector CD8 + T Cell as Key Players in Multiple Myeloma
Joshua, Douglas E, Vuckovic, Slavica, Favaloro, James, Lau, Ka Hei Aleks, Yang, Shihong, Bryant, Christian E, Gibson, John, Ho, Phoebe Joy
Published in Frontiers in immunology (23.02.2021)
Published in Frontiers in immunology (23.02.2021)
Get full text
Journal Article
Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group
Talaulikar, Dipti, Joshua, Douglas, Ho, Phoebe Joy, Gibson, John, Quach, Hang, Gibbs, Simon, Ling, Silvia, Ward, Christopher, Augustson, Bradley M., Trotman, Judith, Harrison, Simon J., Tam, Constantine S.
Published in Internal medicine journal (01.04.2023)
Published in Internal medicine journal (01.04.2023)
Get full text
Journal Article
Mass Cytometry Discovers Two Discrete Subsets of CD39 - Treg Which Discriminate MGUS From Multiple Myeloma
Marsh-Wakefield, Felix, Kruzins, Annabel, McGuire, Helen M, Yang, Shihong, Bryant, Christian, Fazekas de St Groth, Barbara, Nassif, Najah, Byrne, Scott N, Gibson, John, Brown, Christina, Larsen, Stephen, McCulloch, Derek, Boyle, Richard, Clark, Georgina, Joshua, Douglas, Ho, Phoebe Joy, Vuckovic, Slavica
Published in Frontiers in immunology (02.08.2019)
Published in Frontiers in immunology (02.08.2019)
Get full text
Journal Article
Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma
Brown, Ross D., Spencer, Andrew, Joy Ho, Phoebe, Kennedy, Nola, Kabani, Karieshma, Yang, Shihong, Sze, Daniel M., Aklilu, Esther, Gibson, John, Joshua, Douglas E.
Published in Leukemia & lymphoma (01.11.2009)
Published in Leukemia & lymphoma (01.11.2009)
Get full text
Journal Article
A Prospective, Multinational Study of Clinical and Biological Factors Associated with Short Overall Survival in Multiple Myeloma
Tang, Andy, Kim, Kihyun, Chen, Fiona, McQuilten, Zoe K, Mollee, Peter, Rajagopal, Rajeev, Quach, Hang, Ho, Phoebe Joy, Harrison, Simon J., Spencer, Andrew, Chng, Wee-Joo
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Impact of 1q21 Gain and Amplification on Daratumumab-Treated Multiple Myeloma Patients: Real-World Data from the Australia-New Zealand and Asia-Pacific Myeloma and Related Diseases Registries
Lim, Kenneth J C, Wellard, Cameron, Moore, Elizabeth, Ninkovic, Slavisa, Chng, Wee-Joo, Spencer, Andrew, Mollee, Peter, Hocking, Jay, Ho, Phoebe Joy, Janowski, Wojt, Kim, Kihyun, Dun, Karen, McQuilten, Zoe K, Chen, Fiona, Quach, Hang
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Carfilzomib Use Among Patients with Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: Characteristics and Outcomes By Regimen from a Prospective, Real-World Study
Quach, Hang, Yoon, Sung-Soo, Kim, Kihyun, Lee, Ji Hyun, Nagarajan, Chandramouli, Ho, Phoebe Joy, Low, Michael S.Y., Huang, Wei-Han, Wong, Raymond, Liao, Nina, Lin, ChingFeng, Britland, Matthew, Li, Julia, Chai, Stella, Kim, Jin Seok
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma
Sia, Hanlon, Tan, Peter T., Richter, Joshua, Ho, Phoebe Joy, Cochrane, Tara, Quach, Hang, Dhakal, Binod, Proscurshim, Igor, Jiang, Tony, Mancino, Emaryn, Salhi, Yacine, Stefano, Sammicheli, Gudi, Girish, Garton, Andrew, Feldman, Eric J., Spencer, Andrew
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
The Impact of S-Li-M Criteria in Myeloma in a Real-Life Population: Patient & Disease Characteristics, Treatment and Outcomes from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
Ho, Phoebe Joy, Moore, Elizabeth M., Wellard, Cameron, Quach, Hang, Blacklock, Hilary, Harrison, Simon J, McDonald, Emma-Jane, McQuilten, Zoe, Wood, Erica M., Mollee, Peter, Spencer, Andrew
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Initial Dose Escalation of ISB 1442, a Novel CD38 Biparatopic x CD47 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
Kazandjian, Dickran, Quach, Hang, Sia, Hanlon, Ho, Phoebe Joy, Spencer, Andrew, Schroeder, Mark A., Dhakal, Binod, Cochrane, Tara, Zonder, Jeffrey A., Yi, Nancy, Duchesne, Dominique, Shah, Tejas, Garton, Andrew, Menon, Vinu, Gn, Sunitha, Sammicheli, Stefano, Zhukovsky, Eugene, Konto, Cyril, Pacaud, Lida, Tan, Peter
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
P-070 Failure to clear circulating tumor cells after one week of daratumumab, bortezomib and dexamethasone is associated with a reduced progression-free survival for myeloma patients
Bryant, Christian, Abadir, Edward, Doo, Nicole Wong, Bryant, Adam, McCaughan, Georgia, Yang, Shihong, Vanguru, Vinay, King, Tracy, Joshua, Douglas, Ho, Phoebe Joy
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
P-289 The efficacy and safety of prednisone, cyclophosphamide, doxorubicin and carmustine (PCAB) in relapsed/refractory multiple myeloma in the era of novel therapy, including as a bridge to CAR-T therapy
Li, Eric, Bryant, Christian, Jones, Esther, King, Tracy, Talaulikar, Dipti, Ng, Jun, Bryant, Adam, Ridha, Zainab, Doo, Nicole Wong, Ling, Silvia, Ho, Phoebe Joy, Joshua, Douglas
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study
McGuirk, Joseph P., Tam, Constantine S., Kröger, Nicolaus, Riedell, Peter A., Murthy, Hemant S., Ho, Phoebe Joy, Maakaron, Joseph E., Waller, Edmund K., Awan, Farrukh T., Shaughnessy, Paul J., Ghobadi, Armin, Bishop, Michael R., Alfonso-Pierola, Ana, Dickinson, Michael, Ramakrishnan Geethakumari, Praveen, Ross, Ainsley, Stevens, William, Xu, Huansheng, Ma, Anna, Cohen, Sarah Beaussant, Maziarz, Richard T., Bachier, Carlos
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up
Schuster, Stephen J, Fowler, Nathan, Dickinson, Michael, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason, Ghosh, Monalisa, Popplewell, Leslie L., Chavez, Julio C, Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie José, Andreadis, Charalambos, Riedell, Peter A, Ho, Phoebe Joy, Perez-Simon, Jose A., Chen, Andy, Nastoupil, Loretta J., von Tresckow, Bastian, Ferreri, Andrés José María, Teshima, Takanori, Patten, Piers, McGuirk, Joseph P, Petzer, Andreas L, Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Awasthi, Rakesh, Paule, Ines, Germano, Davide, Ramos, Roberto Javier, Hsu, Pei, Thieblemont, Catherine, Dreyling, Martin
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
Chai, Khai Li, Wellard, Cameron, Moore, Elizabeth M., Augustson, Bradley, Bapat, Akshay, Blacklock, Hilary Anne, Cooke, Rachel Elizabeth, Forsyth, Cecily, Hamad, Nada, Harrison, Simon J, Ho, Phoebe Joy, Hocking, Jay, Kerridge, Ian H., King, Tracy, McCaughan, Georgia J, Mollee, Peter, Morrissey, Orla, Murphy, Nicholas E., Quach, Hang, Tan, Xuan Ni, Wong, Kimberly, Spencer, Andrew, Wood, Erica M., McQuilten, Zoe
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article